α-Lipoic acid suppresses migration and invasion via downregulation of cell surface β1-integrin expression in bladder cancer cells

Journal of Clinical Biochemistry and Nutrition

Volumn 54, Issue 1, 2014, Pages 18-25

  Yamasaki, Masao ^a   Iwase, Masahiro ^a   Kawano, Kazuo ^a   Sakakibara, Yoichi ^a   Suiko, Masahito ^a   Ikeda, Masahiro ^a   Nishiyama, Kazuo ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

lipoic acid; 1 integrin; Bladder cancer cells; Invasion; Migration

Indexed keywords

BETA1 INTEGRIN; F ACTIN; FOCAL ADHESION KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; THIOCTIC ACID;

ANTIGEN EXPRESSION; ARTICLE; BLADDER CANCER; CANCER CELL; CELL INVASION; CELL MIGRATION; CELL SURFACE; CONTROLLED STUDY; ENZYME INHIBITION; FLUORESCENCE; HUMAN; HUMAN CELL; INTERNALIZATION; INTRACELLULAR SIGNALING; RECEPTOR DOWN REGULATION; STRESS FIBER; WESTERN BLOTTING;

EID: 84891802401     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.13-57     Document Type: Article

References (58)

1. Bamford S, Dawson E, Forbes S, et al. The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. Br J Cancer 2004; 91: 355-358.
2. Karnoub AE, Weinberg RA. Ras oncogenes: split personalities. Nat Rev Mol Cell Biol 2008; 9: 517-531.
3. Schubbert S, Shannon K, Bollag G. Hyperactive Ras in developmental disorders and cancer. Nat Rev Canser 2007; 7: 295-308.
4. Irani K, Xia Y, Zweier JL, et al. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 1997; 275: 1649-1652.
5. Zaitsu H, Tanaka H, Mitsudomi T, Matsuzaki A, Ohtsu M, Kimura G. Differences in proliferation properties among sublines of rat 3Y1 fibroblasts transformed by various agents in vitro. Biomed Res 1998; 9: 181-197.
6. Yamasaki M, Omi Y, Fujii N, et al. Mustard oil in "Shibori Daikon" a variety of Japanese radish, selectively inhibits the proliferation of H-ras-transformed 3Y1 cells. Biosci Biotechnol Biochem 2009; 73: 2217-2221.
7. Yamasaki M, Iwase M, Kawano K, Sakakibara Y, Suiko M, Nishiyama K. Alpha lipoic acid selectively inhibits proliferation and adhesion to fibronectin of v-H-ras-transformed 3Y1 cells. J Clin Biochem Nutr 2012; 50: 234-240.
8. Yamasaki M, Kawabe A, Nishimoto K, et al. Dihydro-alpha-lipoic acid has more potent cytotoxicity than alpha-lipoic acid. In Vitro Cell Dev Biol Anim 2009; 45: 275-280.
9. Simbula G, Columbano A, Ledda-Columbano GM, et al. Increased ROS generation and p53 activation in alpha-lipoic acid-induced apoptosis of hepatoma cells. Apoptosis 2007; 12: 113-123.
10. Wenzel U, Nickel A, Daniel H. Alpha-Lipoic acid induces apoptosis in human colon cancer cells by increasing mitochondrial respiration with a concomitant O2-*-generation. Apoptosis 2005; 10: 359-368.
11. Lee HS, Na MH, Kim WK. Alpha-Lipoic acid reduces matrix metalloproteinase activity in MDA-MB-231 human breast cancer cells. Nutr Res 2010; 30: 403-409.
12. Kiaris H, Spandidos D. Mutations of ras genes in human tumours (review). Int J Oncol 1995; 7: 413-421.
13. Adjei AA. Blocking oncogenic Ras signaling for cancer therapy. J Natl Cancer Inst 2001; 93: 1062-1074.
14. Wang AX, Chang JW, Li CY, Liu K, Lin YL. H-ras mutation detection in bladder cancer by COLD-PCR analysis and direct sequencing. Urol Int 2012; 88: 350-357.
15. Johne A, Roots I, Brockmöller J. A single nucleotide polymorphism in the human H-ras proto-oncogene determines the risk of urinary bladder cancer. Cancer Epidemiol Biomarkers Prev 2003; 12: 68-70.
16. Przybojewska B, Jagiello A, Jalmuzna P. H-RAS, K-RAS, and N-RAS gene activation in human bladder cancers. Cancer Genet Cytogenet 2000; 121: 73-77.
17. Saito S, Hata M, Fukuyama R, et al. Screening of H-ras gene point mutations in 50 cases of bladder carcinoma. Int J Urol 1997; 4: 178-185.
18. Taparowsky E, Suard Y, Fasano O, Shimizu K, Goldfarb M, Wigler M. Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change. Nature 1982; 300: 762-765.
19. Nista A, Mattioni M, Gismondi A, Palmieri G, Santoni A. Beta 1-Integrin expression and function in human bladder cancer cells: modulation by TNF alpha. Anticancer Res 1996; 16: 581-588.
20. Laidler P, Gil D, Pituch-Noworolska A, et al. Expression of beta1-integrins and N-cadherin in bladder cancer and melanoma cell lines. Acta Biochim Pol 2000; 47: 1159-1170.
21. Heyder C, Gloria-Maercker E, Hatzmann W, Niggemann B, Zänker KS, Dittmar T. Role of the beta1-integrin subunit in the adhesion, extravasation and migration of T24 human bladder carcinoma cells. Clin Exp Metastasis 2005; 22: 99-106.
22. Humphries MJ, Newham P. The structure of cell-adhesion molecules. Trends Cell Biol 1998; 8: 78-83.
23. Buccione R, Orth JD, McNiven MA. Foot and mouth: podosomes, invadopodia and circular dorsal ruffles. Nat Rev Mol Cell Biol 2004; 5: 647-657.
24. Mueller SC, Chen WT. Cellular invasion into matrix beads: localization of beta 1 integrins and fibronectin to the invadopodia. J Cell Sci 1991; 99: 213-225.
25. Mierke CT, Frey B, Fellner M, Herrmann M, Fabry B. Integrin á5â1 facilitates cancer cell invasion through enhanced contractile forces. J Cell Sci 2011; 124: 369-383.
26. Chan PY, Kanner SB, Whitney G, Aruffo A. A transmembrane-anchored chimeric focal adhesion kinase is constitutively activated and phosphorylated at tyrosine residues identical to pp125FAK. J Biol Chem 1994; 269: 20567- 20574.
27. Igishi T, Fukuhara S, Patel V, Katz BZ, Yamada KM, Gutkind JS. Divergent signaling pathways link focal adhesion kinase to mitogen-activated protein kinase cascades. Evidence for a role of paxillin in c-Jun NH(2)-terminal kinase activation. J Biol Chem 1999; 274: 30738-30746.
28. Marracci GH, McKeon GP, Marquardt WE, Winter RW, Riscoe MK, Bourdette DN. Alpha lipoic acid inhibits human T-cell migration: implications for multiple sclerosis. J Neurosci Res 2004; 78: 362-370.
29. Thamilselvan V, Craig DH, Basson MD. FAK association with multiple signal proteins mediates pressure-induced colon cancer cell adhesion via a Src-dependent PI3K/Akt pathway. FASEB J 2007; 21: 1730-1741.
30. Bouchard V, Demers MJ, Thibodeau S, et al. Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways. J Cell Physiol 2007; 212: 717-728.
31. Marracci GH, Jones RE, McKeon GP, Bourdette DN. Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis. J Neuroimmunol 2002; 131: 104-114.
32. Parsons JT, Martin KH, Slack JK, Taylor JM, Weed SA. Focal adhesion kinase: a regulator of focal adhesion dynamics and cell movement. Oncogene 2000; 19: 5606-5613.
33. Schmidmaier R, Baumann P. ANTI-ADHESION evolves to a promising therapeutic concept in oncology. Curr Med Chem 2008; 15: 978-990.
34. Bustelo XR, Sauzeau V, Berenjeno IM. GTP-binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo. Bioessays 2007; 29: 356-370.
35. Schwartz L, Abolhassani M, Guais A, et al. A combination of alpha lipoic acid and calcium hydroxycitrate is efficient against mouse cancer models: preliminary results. Oncol Rep 2010; 23: 1407-1416.
36. Guais A, Baronzio G, Sanders E, et al. Adding a combination of hydroxycitrate and lipoic acid (METABLOCTM) to chemotherapy improves effectiveness against tumor development: experimental results and case report. Invest New Drugs 2012; 30: 200-211.
37. Dominguez-Escrig JL, Kelly JD, Neal DE, King SM, Davies BR. Evaluation of the therapeutic potential of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in preclinical models of bladder cancer. Clin Cancer Res 2004; 10: 4874-4884.
38. Min AK, Kim MK, Seo HY, et al. Alpha-lipoic acid inhibits hepatic PAI-1 expression and fibrosis by inhibiting the TGF-beta signaling pathway. Biochem Biophys Res Commun 2010; 393: 536-541.
39. Lee WR, Kim A, Kim KS, et al. Alpha-lipoic acid attenuates atherosclerotic lesions and inhibits proliferation of vascular smooth muscle cells through targeting of the Ras/MEK/ERK signaling pathway. Mol Biol Rep 2012; 39: 6857-6866.
40. Hughes PE, Renshaw MW, Pfaff M, et al. Suppression of integrin activation: a novel function of a Ras/Raf-initiated MAP kinase pathway. Cell 1997; 88: 521-530.
41. Hughes PE, Oertli B, Hansen M, Chou FL, Willumsen BM, Ginsberg MH. Suppression of integrin activation by activated Ras or Raf does not correlate with bulk activation of ERK MAP kinase. Mol Biol Cell 2002; 13: 2256-2265.
42. Gahmberg CG, Fagerholm SC, Nurmi SM, Chavakis T, Marchesan S, Grönholm M. Regulation of integrin activity and signalling. Biochim Biophys Acta 2009; 1790: 431-444.
43. Pocheć E, Lityńska A, Bubka M, Amoresano A, Casbarra A. Characterization of the oligosaccharide component of alpha3beta1 integrin from human bladder carcinoma cell line T24 and its role in adhesion and migration. Eur J Cell Biol 2006; 85: 47-57.
44. del Pozo MA, Alderson NB, Kiosses WB, Chiang HH, Anderson RG, Schwartz MA. Integrins regulate Rac targeting by internalization of membrane domains. Science 2004; 303: 839-842.
45. Cheng ZJ, Singh RD, Sharma DK, et al. Distinct mechanisms of clathrinindependent endocytosis have unique sphingolipid requirements. Mol Biol Cell 2006; 17: 3197-3210.
46. Palazzo AF, Eng CH, Schlaepfer DD, Marcantonio EE, Gundersen GG. Localized stabilization of microtubules by integrin- and FAK-facilitated Rho signaling. Science 2004; 303: 836-839.
47. Ren XD, Wang R, Li Q, Kahek LA, Kaibuchi K, Clark RA. Clark Disruption of Rho signal transduction upon cell detachment. J Cell Sci 2004; 117: 3511-3518.
48. Echarri A, Muriel O, Del Pozo MA. Intracellular trafficking of raft/caveolae domains: insights from integrin signaling. Semin Cell Dev Biol 2007; 18: 627-637.
49. Gu Z, Noss EH, Hsu VW, Brenner MB. Integrins traffic rapidly via circular dorsal ruffles and macropinocytosis during stimulated cell migration. J Cell Biol 2011; 193: 61-70.
50. Caswell P, Norman J. Endocytic transport of integrins during cell migration and invasion. Trends Cell Biol 2008; 18: 257-263.
51. Boyd ND, Chan BM, Petersen NO. Beta1 integrins are distributed in adhesion structures with fibronectin and caveolin and in coated pits. Biochem Cell Biol 2003; 81: 335-348.
52. Panicker AK, Buhusi M, Erickson A, Maness PF. Endocytosis of beta1 integrins is an early event in migration promoted by the cell adhesion molecule L1. Exp Cell Res 2006; 312: 299-307.
53. Sharma DK, Brown JC, Cheng Z, Holicky EL, Marks DL, Pagano RE. The glycosphingolipid, lactosylceramide, regulates beta1-integrin clustering and endocytosis. Cancer Res 2005; 65: 8233-8241.
54. Thorne RF, Marshall JF, Shafren DR, Gibson PG, Hart IR, Burns GF. The integrins alpha3beta1 and alpha6beta1 physically and functionally associate with CD36 in human melanoma cells. Requirement for the extracellular domain of CD36. J Biol Chem 2000; 275: 35264-35275.
55. Vassilieva EV, Gerner-Smidt K, Ivanov AI, Nusrat A. Lipid rafts mediate internalization of beta1-integrin in migrating intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 2008; 295: G965-G976.
56. Zhang CJ, Shen ZJ, Pan CW, Zhong S, Li T, Zhang MG. Engagement of integrinß1 induces resistance of bladder cancer cells to mitomycin-C. Urology 2012; 79: 638-643.
57. Saito T, Kimura M, Kawasaki T, Sato S, Tomita Y. Correlation between integrin alpha 5 expression and the malignant phenotype of transitional cell carcinoma. Br J Cancer 1996; 73: 327-331.
58. Pan CW, Shen ZJ, Wu TT, et al. Cell adhesion to fibronectin induces mitomycin C resistance in bladder cancer cells. BJU Int 2009; 104: 1774-1779.